DRKS00031897
Completed
Not Applicable
A prospective non-interventional study to assess quality of life and COPDsymptoms in patients with COPD on LAMA/LABA/ICS triple therapy withElebrato® Ellipta® - ELLLITHE, Study number: BC Be/20/ELE-NIS/01
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- J44.9
- Sponsor
- BERLIN-CHEMIE AG
- Enrollment
- 931
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients \=18 years, with moderate to severe COPD (FEV1 \=30% \- \<80%)
- •2\. Decision for the therapy with Elebrato Ellipta was made in accordance with the current registration and independently from the participation in this NIS,
- •3\. Patients with at least one COPD exacerbation within the last 12 months prior to starting treatment with Elebrato Ellipta,
- •4\. Patients with a CAT \= 10 prior to starting treatment with Elebrato Ellipta,
- •5\. Patient treated with Elebrato Ellipta for the first time; this includes patients already on Elebrato Ellipta for a maximum of 4 weeks prior to enrolment into
- •this NIS, and whose COPD medication was not changed during this period,
- •6\. Patients who are willing and able to give their written consent to the use of their pseudonymized personal information for the purposes of this study.
Exclusion Criteria
- •1\. Patients hospitalized due to COPD exacerbation within the last 4 weeks prior to enrolment,
- •2\. Participation in a clinical trial within the last 30 days prior to inclusion in this NIS,
- •3\. Any contraindication as per the SmPC of Elebrato Ellipta.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
A prospective non-interventional study to evaluate the effect of Triptorelin Embonate (Diphereline (Trademark TM) 11.25mg) on lower urinary tract symptoms (LUTS) in Australian prostate cancer patients.ocally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Locally advanced or metastatic prostate cancer with Lower Urinary Tract Symptoms (LUTS)Cancer - ProstateRenal and Urogenital - Other renal and urogenital disordersACTRN12610000558022Ipsen Pty Ltd70
Not yet recruiting
Not Applicable
A non-interventional, prospective study to evaluate change in physical activity, relationship satisfaction and psychological well-being in patients with rheumatoid arthritis after introduction of the JAK inhibitor filgotinib and also in their partners.M06.8Other specified rheumatoid arthritisDRKS00032128Helios Fachklinik Vogelsang-Gommern, Rheumatologie40
Completed
Not Applicable
A prospective, non-interventional study to investigate the effectiveness of a recombinant fusion protein linking coagulation Factor IX with recombinant albumin (rIX-FP) in patients with hemophilia BD67Hereditary factor IX deficiencyDRKS00015079CSL Behring GmbH73
Completed
Not Applicable
A retrospective non-interventional study evaluating retention rate of Everolimus as add-on epilepsy therapy in adult patients with tuberose sclerosisQ85.1Tuberous sclerosisDRKS00020248Epilepsiezentrum Kork45
Not yet recruiting
Phase 3
To observe the effect of extension of epidural space with normal saline on the effect of spinal anaesthesia using low dose of local anaesthetic i.e., high density BUPIVACAINE in patients undergoing infraumbilical surgeriesHealth Condition 1: I839- Asymptomatic varicose veins of lower extremitiesHealth Condition 2: S720- Fracture of head and neck of femurHealth Condition 3: R103- Pain localized to other parts of lower abdomenCTRI/2023/04/051776ESIC Medical College and Hospital